ACHE and early-onset autosomal dominant Alzheimer disease: Astaxanthin also displayed acetylcholinesterase (AChE) inhibitory activity, with an IC50 value of 297.99 μg mL−1, which is comparable to galantamine (4.11 μg mL−1), a standard treatment for Alzheimer’s disease.